Systemic chemotherapy and tamoxifen induced regression of choroidal metastasis from a breast carcinoma in a male.
Indian J Ophthalmol
;
2007 Nov-Dec; 55(6): 475-7
Article
in English
| IMSEAR
| ID: sea-70357
ABSTRACT
We report a case of a 55-year-old male patient with breast carcinoma, who developed choroidal metastasis. The patient had undergone mastectomy for carcinoma of right breast, five years ago. The patient was advised close follow-up for the left eye, as he was already on tamoxifen therapy (started a month ago) for spinal metastasis. On last follow-up, a year later, the choroidal lesion had completely scarred, with no recurrences. Systemic hormonal therapy like tamoxifen given for the breast primary and other systemic metastases may cause regression of the choroidal metastasis, thereby avoiding ocular radiotherapy. Medline search revealed only one published case of regression of choroidal metastasis from a male breast primary, on tamoxifen therapy.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Tamoxifen
/
Humans
/
Male
/
Carcinoma
/
Fluorescein Angiography
/
Choroid Neoplasms
/
Administration, Oral
/
Follow-Up Studies
/
Breast Neoplasms, Male
/
Selective Estrogen Receptor Modulators
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Indian J Ophthalmol
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS